Literature DB >> 17595761

Beclin 1 gene inhibits tumor growth in colon cancer cell lines.

Kenji Koneri1, Takanori Goi, Yasuo Hirono, Kanji Katayama, Akio Yamaguchi.   

Abstract

BACKGROUND: The Beclin 1 gene binds to the apoptosis-inhibiting protein Bcl-2. The expression and function of the Beclin 1 gene in four colorectal cancer cell lines (HT29, DLD-1, SW480, SW620) was investigated.
MATERIALS AND METHODS: The expression of Beclin 1 mRNA was examined by reverse transcription-polymerase chain reaction (RT-PCR), the cell growth rate of a stable cell line established after transfection of the Beclin 1 gene into low Beclin 1-expressing HT29 colon cancer cells. In addition, changes in cell cycle were investigated by flow cytometry, and the expression levels of cell cycle related proteins in the Beclin 1 transfected colon cancer cell line were assessed.
RESULTS: The expression level of Beclin 1 mRNA in the colon cancer cell lines was variable. Transfection of the low Beclin 1 gene-expressing colon cancer cell line with the Beclin 1 gene resulted in cell growth inhibition. The cell cycle analysis showed that the percentage of GJ-phase cells was significantly higher in Beclin 1 transfectants than in mock transfected cells. The expression levels of cyclin E and phosphorylated Rb were decreased.
CONCLUSION: These results indicate that Beclin 1 can inhibit the growth of colorectal cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595761

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  42 in total

Review 1.  Autophagy and cancer.

Authors:  Li Yen Mah; Kevin M Ryan
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

2.  The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.

Authors:  Heather B Roesly; Mohammad R Khan; Hwu Dau Rw Chen; Kimberly A Hill; Nirushan Narendran; George S Watts; Xiaoxin Chen; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-02       Impact factor: 4.052

Review 3.  Autophagy: molecular machinery, regulation, and implications for renal pathophysiology.

Authors:  Sudharsan Periyasamy-Thandavan; Man Jiang; Patricia Schoenlein; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-11

Review 4.  Autophagy: for better or for worse.

Authors:  Ellen Wirawan; Tom Vanden Berghe; Saskia Lippens; Patrizia Agostinis; Peter Vandenabeele
Journal:  Cell Res       Date:  2011-09-13       Impact factor: 25.617

Review 5.  Autophagy modulation as a target for anticancer drug discovery.

Authors:  Xin Li; Huai-long Xu; Yong-xi Liu; Na An; Si Zhao; Jin-ku Bao
Journal:  Acta Pharmacol Sin       Date:  2013-04-08       Impact factor: 6.150

Review 6.  Conformational flexibility of BECN1: Essential to its key role in autophagy and beyond.

Authors:  Yang Mei; Karen Glover; Minfei Su; Sangita C Sinha
Journal:  Protein Sci       Date:  2016-08-13       Impact factor: 6.725

7.  Beclin 1 expression is associated with the occurrence and development of esophageal squamous cell carcinoma.

Authors:  Hailei Du; Jiamin Che; Minmin Shi; Lianggang Zhu; Jun Biao Hang; Zhongyuan Chen; Hecheng Li
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967

8.  Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.

Authors:  Xifeng Wang; Ziyan Du; Lingyun Li; Minhua Shi; Yong Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Authors:  Miao Yu; Wen-feng Gou; Shuang Zhao; Li-jun Xiao; Xiao-yun Mao; Ya-nan Xing; Hiroyuki Takahashi; Yasuo Takano; Hua-chuan Zheng
Journal:  Tumour Biol       Date:  2013-01-19

10.  Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression.

Authors:  Yongshun Chen; You Lu; Changli Lu; Lei Zhang
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.